Lactobacillus plantarum XKFY202518 and application thereof in preparation of 2-type diabetes auxiliary preparation for improving insulin resistance and regulating blood lipid
By preparing Lactobacillus plantarum XKFY202518 bacterial agent, combined with prebiotics and fillers, the problem of adverse effects of existing drugs on the body was solved, and insulin resistance and dyslipidemia in type 2 diabetic mice were improved.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- CHONGQING UNIV OF EDUCATION
- Filing Date
- 2026-01-14
- Publication Date
- 2026-05-29
AI Technical Summary
Existing medications for treating type 2 diabetes have many adverse effects on the body, necessitating the development of highly effective and safe probiotic preparations to improve insulin resistance and regulate blood lipids.
A bacterial agent was prepared using Lactobacillus plantarum XKFY202518, and combined with prebiotics, fillers and excipients. Through cultivation, centrifugation and freeze-drying, it was prepared into an adjunct preparation for improving insulin resistance and regulating blood lipids in type 2 diabetes.
It effectively reduces fasting blood glucose, insulin, total cholesterol, triglycerides and low-density lipoprotein cholesterol levels in diabetic mice, while increasing high-density lipoprotein cholesterol levels, reducing pancreatic and liver tissue damage, and improving symptoms of hyperglycemia and hyperlipidemia.
Smart Images

Figure CN122104489A_ABST